![Page Image](https://mumcdnstorage.blob.core.windows.net/dwnews/2020/02/Cardionerds_v2.1_square-e1652991097644.png)
CardioNerds
The CardioNerds—Amit Goyal, MD, and Daniel Ambinder, MD—cover cardiology concepts in an engaging format that features leaders in the industry, as well as up-and-coming voices in residency and fellowship. They aim to improve health equitably by providing timely and insightful cardiovascular health news.
The CardioNerds and Dr. Alexander discuss the findings of the ATTRibute-CM clinical trial.
The CardioNerds and Dr. Alexander analyze biomarkers in ATTR-CM.
The CardioNerds and Dr. Kevin M. Alexander discuss the nuances of transthyretin amyloid cardiomyopathy.
Treatment-related early increase in serum transthyretin levels are associated with reduced CV-related hospitalizations.
A study uncovered surprising findings regarding the presence and nature of transthyretin in stenotic aortic valves.
A study investigated the prevalence and implications of ATTR-CA across different heart failure phenotypes.
A case series explored the impact of possessing more than 1 pathogenic variant of the TTR gene on the severity of ATTR.
A study underscores the importance of NT-proBNP as a biomarker in stratifying disease severity in ATTR-CA.
Advertisement
DocWire News delivers the latest medical industry news, giving health care professionals the curated content most relevant to their fields and practices.
Get the latest updates from DocWire News experts, including the CardioNerds.
Advertisement